REVBEKITUG
UNII D5A36J9RSC

Substance Identification & Data

This profile provides standardized clinical and technical data for Revbekitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D5A36J9RSC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3031358-43-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D5A36J9RSC
CAS Registry Number
3031358-43-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
REVBEKITUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224784
National Cancer Institute reference terminology for clinical and research data.
INN ID
13700
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
Revbekitug
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Revbekitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Revbekitug

Common Names & Synonyms

H-gamma1 heavy chain (1-449) [VH Musmus/Homsap (Mus musculus IGHV1-86*02 (84.7%) -(IGHD) -IGHJ1*01 (82.4%) A120>Q (111), T123>L (114)/Homo sapiens IGHV1-46*01 (79.6%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT [8.8.12] (26-33.51-58.97-108)) (1-119) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (216) (120-217), hinge 1-15 (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)], (222-214')-disulfide with L-kappa light chain (1'-214') [V-KAPPA Musmus/Homsap (Mus musculus IGKV14-111*01 (81.1%) -IGKJ2*03 (83.3%) S120>Q (100'), L124>V (104')/Homo sapiens IGKV1-16*01 (81.1%) -IGKJ2*01 (91.7%) L124>V (104'), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (228-228'':231-231'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, lacking the glutamine synthetase (GS-KO) gene, glycoform alfa
Immunoglobulin G1, anti-(human interleukin 5) (human-Mus musculus monoclonal 610 γ1-chain), disulfide with human-Mus musculus monoclonal 610 κ-chain, dimer
immunoglobulin G1-kappa, anti-[Homo sapiens IL5 (interleukin 5, IL-5)], monoclonal antibody (revbekitug)
revbekitug [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus